In TCGA ovarian cancer database, we found that MRPL15 expression was significantly related to the difference in the immune subtype of ovarian cancer, and its expression in C3 ovarian cancer was significantly lower than in the other three types (p < 0.0001, Figure 9A). Here, MRPL15 is linked to ovarian cancer.